Yamashita T - Search Results

1

Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer.

Satoh A, Toyota M, Itoh F, Sasaki Y, Suzuki H, Ogi K, Kikuchi T, Mita H, Yamashita T, Kojima T, Kusano M, Fujita M, Hosokawa M, Endo T, Tokino T, Imai K. Satoh A, et al. Among authors: yamashita t. Cancer Res. 2003 Dec 15;63(24):8606-13. Cancer Res. 2003. PMID: 14695171

2

The p53 family member genes are involved in the Notch signal pathway.

Sasaki Y, Ishida S, Morimoto I, Yamashita T, Kojima T, Kihara C, Tanaka T, Imai K, Nakamura Y, Tokino T. Sasaki Y, et al. Among authors: yamashita t. J Biol Chem. 2002 Jan 4;277(1):719-24. doi: 10.1074/jbc.M108080200. Epub 2001 Oct 18. J Biol Chem. 2002. PMID: 11641404 Free article.

3

Identification of the interleukin 4 receptor alpha gene as a direct target for p73.

Sasaki Y, Mita H, Toyota M, Ishida S, Morimoto I, Yamashita T, Tanaka T, Imai K, Nakamura Y, Tokino T. Sasaki Y, et al. Among authors: yamashita t. Cancer Res. 2003 Dec 1;63(23):8145-52. Cancer Res. 2003. PMID: 14678968

4

Identification of SCN3B as a novel p53-inducible proapoptotic gene.

Adachi K, Toyota M, Sasaki Y, Yamashita T, Ishida S, Ohe-Toyota M, Maruyama R, Hinoda Y, Saito T, Imai K, Kudo R, Tokino T. Adachi K, et al. Among authors: yamashita t. Oncogene. 2004 Oct 14;23(47):7791-8. doi: 10.1038/sj.onc.1208067. Oncogene. 2004. PMID: 15334053

5

A case of systemic osteomyelitides due to Mycobacterium avium.

Yamashita T, Endo T, Hamamoto Y, Akiba H, Ono I, Jimbow K. Yamashita T, et al. J Dermatol. 2004 Dec;31(12):1036-40. doi: 10.1111/j.1346-8138.2004.tb00651.x. J Dermatol. 2004. PMID: 15801272

6

Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines.

Oshima Y, Sasaki Y, Negishi H, Idogawa M, Toyota M, Yamashita T, Wada T, Nagoya S, Kawaguchi S, Yamashita T, Tokino T. Oshima Y, et al. Among authors: yamashita t. Cancer Biol Ther. 2007 Jul;6(7):1058-66. doi: 10.4161/cbt.6.7.4320. Cancer Biol Ther. 2007. PMID: 17568187 Free article.

7

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer.

Maruyama R, Akino K, Toyota M, Suzuki H, Imai T, Ohe-Toyota M, Yamamoto E, Nojima M, Fujikane T, Sasaki Y, Yamashita T, Watanabe Y, Hiratsuka H, Hirata K, Itoh F, Imai K, Shinomura Y, Tokino T. Maruyama R, et al. Among authors: yamashita t. Carcinogenesis. 2008 Jul;29(7):1312-8. doi: 10.1093/carcin/bgn060. Epub 2008 Feb 29. Carcinogenesis. 2008. PMID: 18310659 Free PMC article.

8

Cancer epigenomics: implications of DNA methylation in personalized cancer therapy.

Toyota M, Suzuki H, Yamashita T, Hirata K, Imai K, Tokino T, Shinomura Y. Toyota M, et al. Among authors: yamashita t. Cancer Sci. 2009 May;100(5):787-91. doi: 10.1111/j.1349-7006.2009.01095.x. Epub 2009 Feb 19. Cancer Sci. 2009. PMID: 19236379 Free PMC article. Review.

9

N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.

Sato M, Yamashita T, Ohkura M, Osai Y, Sato A, Takada T, Matsusaka H, Ono I, Tamura Y, Sato N, Sasaki Y, Ito A, Honda H, Wakamatsu K, Ito S, Jimbow K. Sato M, et al. Among authors: yamashita t. J Invest Dermatol. 2009 Sep;129(9):2233-41. doi: 10.1038/jid.2009.39. Epub 2009 Mar 19. J Invest Dermatol. 2009. PMID: 19295615 Free article.

10

[Molecular mechanisms involved in epigenetic alterations in cancer].

Toyota M, Suzuki H, Nishizaka T, Sato A, Yamashita T. Toyota M, et al. Among authors: yamashita t. Gan To Kagaku Ryoho. 2010 Sep;37(9):1650-3. Gan To Kagaku Ryoho. 2010. PMID: 20841926 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,914 results

Search Page

Filters